Isabelle Martel‐Lafay
-
- Lung Cancer Diagnosis and Treatment 20
- Lung Cancer Treatments and Mutations 14
- Gastric Cancer Management and Outcomes 6
- Otorhinolaryngology top 5%
- Radiation top 10%
- Advanced Radiotherapy Techniques 12
- Oncology top 10%
- Lung Cancer Research Studies 7
- Colorectal Cancer Surgical Treatments 5
- Surgery top 10%
- Colorectal and Anal Carcinomas 8
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Co-authors
- D. ArpinThierry ConroyBéata JuzynaM. PérolJean‐Yves DouillardLaurent BedenneMarie‐Pierre GalaisJean‐Luc Raoul
- Journals
- Journal of Clinical Oncology (7 papers)The Lancet Oncology (1 paper)International Journal of Radiation Oncology*Biology*Physics (4 papers)
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
Isabelle Martel‐Lafay
36 papers receiving 804 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 547
- Otorhinolaryngology 54
- Radiation 91
- Oncology 268
- Surgery 423
Countries citing papers authored by Isabelle Martel‐Lafay
This map shows the geographic impact of Isabelle Martel‐Lafay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Martel‐Lafay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Martel‐Lafay more than expected).
Fields of papers citing papers by Isabelle Martel‐Lafay
This network shows the impact of papers produced by Isabelle Martel‐Lafay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Martel‐Lafay. The network helps show where Isabelle Martel‐Lafay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Martel‐Lafay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 4 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 6 | |
| 9 | 2019 | 22 | |
| 10 | 2018 | 25 | |
| 11 | 2018 | 15 | |
| 12 | 2017 | 1 | |
| 13 | 2015 | 31 | |
| 14 | Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trialbreakdown → | 2014 | 276 |
| 15 | 2014 | 5 | |
| 16 | 2013 | 60 | |
| 17 | 2010 | 48 | |
| 18 | 2008 | 6 | |
| 19 | 2005 | 121 | |
| 20 | 2003 | 23 |
About Isabelle Martel‐Lafay
Isabelle Martel‐Lafay is a scholar working on Radiation, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 818 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (14 papers), Advanced Radiotherapy Techniques (12 papers), Colorectal and Anal Carcinomas (8 papers), Lung Cancer Research Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Colorectal Cancer Surgical Treatments (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (547 citations), Otorhinolaryngology (54 citations) and Radiation (91 citations). Isabelle Martel‐Lafay has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include D. Arpin, Thierry Conroy, Béata Juzyna, M. Pérol, Jean‐Yves Douillard, Laurent Bedenne, Marie‐Pierre Galais, Jean‐Luc Raoul, S. Gourgou-Bourgade and Pierre Michel. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.